Skip to main content

Radiotherapy in Early Stage Non-Small Cell Lung Cancer

  • Chapter
Advances in Radiation Oncology in Lung Cancer

Part of the book series: Medical Radiology Radiation Oncology ((Med Radiol Radiat Oncol))

  • 892 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alexander E 3rd, Moriarty TM, Davis RB, Wen PY, Fine HA, Black PM, Kooy HM, Loeffler JS (1995) Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 87:34–40

    PubMed  Google Scholar 

  • Armstrong JG, Burman C, Leibel S, Fontenla D, Kutcher G, Zelefsky M, Fuks Z (1993) Three-dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 26:685–689

    PubMed  Google Scholar 

  • Au J, el-Oakley R, Cameron EW (1994) Pneumonectomy for bronchiogenic carcinoma in the elderly. Eur J Cardiothorac Surg 8:247–250

    Article  PubMed  Google Scholar 

  • Ball D, Bishop J, Smith J, O'Brien P, Davis S, Ryan G, Olver I, Toner G, Walker Q, Joseph D (1999) A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial. Radiother Oncol. 52:129–136

    Article  PubMed  Google Scholar 

  • Ball DL, Peters LJ, Smith J (2001) Untitled (letter to the editor). Radiother Oncol 58:89–90

    Article  PubMed  Google Scholar 

  • Bahri S, Flickinger JC, Kalend AM, Deutsch M, Belani CP, Sciurba FC, Luketich JD, Greenberger JS (1999) Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams. Radiat Oncol Invest 7:297–308

    Article  Google Scholar 

  • Belderbos JSA, de Jaeger K, Heemsbergen WD, Seppenwoolde Y, Baas P, Boersma LJ, Lebesque JV (2003) First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. Radiother Oncol 66:119–126

    Article  PubMed  Google Scholar 

  • Bentzen SM, Saunders MI, Dische S (2000) Updated data for CHART in NSCLC: further analyses. Radiother Oncol 55:86–87

    Article  Google Scholar 

  • Black WC, Armstrong P, Daniel TM (1988) Cost effectiveness of chest CT in T1N0M0 lung cancer. Radiology 167:373–378

    PubMed  Google Scholar 

  • Blomgren H, Lax I, Naslund I, Svanstrom R (1995) Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 34:861–870

    PubMed  Google Scholar 

  • Bradley JD, Wahab S, Lockett MA, Perez CA, Purdy JA (2003) Elective nodal failures are uncommon in medically inoperable patients with stage I non-small-cell lung carcinoma treated with limited radiotherapy fields. Int J Radiat Oncol Biol Phys 56:342–347

    Article  PubMed  Google Scholar 

  • Braun SR, doPico GA, Olson CE, Caldwell W (1975) Low-dose radiation pneumonitis. Cancer 35:1322–1324

    PubMed  Google Scholar 

  • Burman C, Kutcher GJ, Emami B, Goitein M (1991) Fitting of normal tissue tolerance data to analytic function. Int J Radiat Oncol Biol Phys 21:123–135

    PubMed  Google Scholar 

  • Byhardt RW, Pajak TF, Emami B, Herskovic A, Doggett RS, Olsen LA (1993) A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of Radiation Therapy Oncology Group 84-07. Int J Radiat Oncol Biol Phys 26:459–468

    PubMed  Google Scholar 

  • Chen M, Jiang G-L, Fu X-L, Wang LJ, Qian H, Chen GY, Zhao S, Liu TF (2000) The impact of overall treatment time on outcomes in radiation therapy for non-small cell lung cancer. Lung Cancer 28:11–19

    Article  PubMed  Google Scholar 

  • Chen ZL, Perez S, Holmes EC, Wang HJ, Coulson WF, Wen DR, Cochran AJ (1993) Frequency and distribution of occult micrometastasis in lymph nodes of patients with non-small cell lung carcinoma. J Natl Cancer Inst 85:493–498

    PubMed  Google Scholar 

  • Cheung PC, Mackillop WJ, Dixon P, Brundage MD, Youssef YM, Zhou S (2000) Involved-field radiotherapy alone for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 48:703–710

    PubMed  Google Scholar 

  • Conces DJ, Jr., Klink JF, Tarver RD, Moak GD (1989) T1N0M0 lung cancer: evaluation with CT. Radiology 170:643–646

    PubMed  Google Scholar 

  • Cooper JFD, Pearson FG, Todd TRJ (1985) Radiotherapy alone for patients with operable carcinoma of the lung. Chest 87:289–292

    PubMed  Google Scholar 

  • Cox JD, Azarnia N, Byhardt RW, Shin KH, Emami B, Pajak TF (1990) A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 to 79.2 Gy-possible survival benefit with > 69.6 Gy in favorable patients with Radiation Therapy Oncology group stage III nonsmall cell lung carcinoma. Report of Radiation Therapy Oncology Group 83-11. J Clin Oncol 8:1543–1555

    PubMed  Google Scholar 

  • Cox JD, Pajak TF, Asbell S, Russell AH, Pederson J, Byhardt RW, Emami B, Roach M 3rd (1993) Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials. Int J Radiat Oncol Biol Phys 27:493–498

    PubMed  Google Scholar 

  • Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for the Treatment and Research of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341–1346

    Article  PubMed  Google Scholar 

  • Coy P, Kennelly GM (1980) The role of curative radiotherapy in the treatment of lung cancer. Cancer 45:698–702

    PubMed  Google Scholar 

  • Dobashi K, Sugio K, Osaki T, Oka T, Yasumoto K (1997) Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance. J Thorac Cardiovsc Surg 114:339–346

    Article  Google Scholar 

  • Dosoretz DE, Katin MJ, Blitzer PH, Rubenstein JH, Salenius S, Rashid M, Dosani RA, Mestas G, Siegel AD, Chadha TT (1992) Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys 25:3–9

    Google Scholar 

  • Dosoretz DE, Galmarini D, Rubenstein JH, Katin MJ, Blitzer PH, Salenius SA, Dosani RA, Rashid M, Mestas G, Hannan SE (1993) Local control in medically inoperable lung cancer: an analysis of its importance in outcome and factors determining the probability of tumour eradication. Int J Radiat Oncol Biol Phys 27:507–516

    PubMed  Google Scholar 

  • Drzymala RE, Mohan R, Brewster L, Chu J, Goitein M, Harms W, Urie M (1991) Dose-volume histograms. Int J Radiat Oncol Biol Phys 21:71–78

    PubMed  Google Scholar 

  • Dunbar SF, Tarbell NJ, Kooy HM, Alexander E 3rd, Black PM, Barnes PD, Goumnerova L, Scott RM, Pomeroy SL, La Vally B (1994) Stereotactic radiotherapy for pediatric and adult brain tumors: preliminary report. Int J Radiat Oncol Biol Phys 30:531–539

    PubMed  Google Scholar 

  • Farrell MA, McAdams HP, Herndon JE, Patz EF Jr (2000) Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease. Radiology 215:886–890

    PubMed  Google Scholar 

  • Firat S, Bousamra M, Gore E, Byhardt RW (2002) Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 52:1047–1057

    Article  PubMed  Google Scholar 

  • Flickinger JC, Kondziolka D, Lunsford LD, Coffey RJ, Goodman ML, Shaw EG, Hudgins WR, Weiner R, Harsh GR 4th, Sneed PK (1994) A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28:797–802

    PubMed  Google Scholar 

  • Fontanini G, Macchiarini P, Pepe S, Ruggiero A, Hardin M, Bigini D, Vignati S, Pingitore R, Angeletti CA (1992) The expression of proliferative cell nuclear antigen in paraffin section of peripheral node-negative non-small cell lung cancer. Cancer 70:1520–1527

    PubMed  Google Scholar 

  • Fukumoto S, Shirato H, Shimizu S, Ogura S, Onimaru R, Kitamura K, Yamazaki K, Miyasaka K, Nishimura M, Dosaka-Akita H (2002) Small-volume image-guided radiotherapy using hypofractionated coplanar and noncoplanar multiple fields with inoperable stage I nonsmall cell lung carcinomas. Cancer 95:1546–1553

    PubMed  Google Scholar 

  • Furuta M, Hayakawa K, Katano S, Saito Y, Nakayama Y, Takahashi T, Imai R, Ebara T, Mitsuhashi N, Niibe H (1996) Radiation therapy for stage I-II non-small cell lung cancer in patients aged 75 years and older. Jpn J Clin Oncol 26:95–98

    PubMed  Google Scholar 

  • Garipagaoglu M, Munley MT, Hollis D, Poulson JM, Bentel GC, Sibley G, Anscher MS, Fan M, Jaszczak RJ, Coleman RE, Marks LB (1999) The effect of patient specific factors on radiation induced regional lung injury. Int J Radiat Oncol Biol Phys 45:3331–3338

    Article  Google Scholar 

  • Gauden S, Tripcony L (2001) The curative treatment by radiation therapy alone of stage I non-small cell lung cancer in a geriatric population. Lung Cancer 32:71–79

    Article  PubMed  Google Scholar 

  • Gauden S, Ramsay J, Tripcony L (1995) The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung. Chest 108:1278–1282

    PubMed  Google Scholar 

  • Ginsberg RJ, Rubinstein L (for the Lung Cancer Study Group) (1995) A randomised study of lobectomy versus limited resection for patients with T1 N0 non-small cell lung cancer. Ann Thorac Surg 60:908–913

    Article  PubMed  Google Scholar 

  • Glazer GM, Orringer MB, Gross BH, Quint LE (1984) The mediastinum in non-small cell lung cancer. Am J Roentgenol 142:1101–1105

    Google Scholar 

  • Graham MV, Matthews JW, Harms WB, Emami B, Glazer HS, Purdy JA (1994) Three-dimensional radiation treatment planning study for patients with carcinoma of the lung. Int J Radiat Oncol Biol Phys 29:1105–1117

    PubMed  Google Scholar 

  • Graham MV, Purdy JA, Emami B, Harms W, Bosch W, Lockett MA, Perez CA (1999) Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45:323–329

    Article  PubMed  Google Scholar 

  • Graham PH, Gebski VJ, Langlands AO (1995) Radical radiotherapy for early nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 31:261–266

    Article  PubMed  Google Scholar 

  • Haffty BG, Goldberg NB, Gerstley J, Fischer DB, Peschel RE (1988) Results of radical radiation therapy in clinical Stage I, technically operable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 15:69–73

    PubMed  Google Scholar 

  • Hara R, Itami J, Kondo T, Aruga T, Abe Y, Ito M, Fuse M, Shinohara D, Nagaoka T, Kobiki T (2002) Stereotactic single high dose irradiation of lung tumors under respiratory gating. Radiother Oncol 63:159–163

    Article  PubMed  Google Scholar 

  • Hayakawa K, Mitsuhashi N, Nakajima N (1992) Radiation therapy for stage III epidermoid carcinoma of the lung. Lung Cancer 8:213–224

    Article  Google Scholar 

  • Hayakawa K, Mitsuhashi N, Saito Y, Nakayama Y, Furuta M, Sakurai H, Kawashima M, Ohno T, Nasu S, Niibe H (1999) Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer. Lung Cancer 26:137–142

    Article  PubMed  Google Scholar 

  • Hayakawa K, Mitsuhashi N, Katano S, Saito Y, Nakayama Y, Sakurai H, Akimoto T, Hasegawa M, Yamakawa M, Niibe H (2001) High-dose radiation therapy for elderly patients with inoperable or unresectable non-small cell lung cancer. Lung Cancer 32:81–88

    Article  PubMed  Google Scholar 

  • Hayman JA, Martel MK, Ten Haken RK, Normolle DP, Todd RF 3rd, Littles JF, Sullivan MA, Possert PW, Turrisi AT, Lichter AS (2001) Dose-escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy. Update of a phase I trial. J Clin Oncol 19:127–136

    PubMed  Google Scholar 

  • Heavey LR, Glazer GM, Gross BH, Francis IR, Orringer MB (1986) The role of CT in staging radiographic T1N0M0 lung cancer. Am J Roentgenol 146:285–290

    Google Scholar 

  • Henschke CI, Wisnivesky JP, Yankelevitz DF, Miettinen OS (2003) Small stage I cancers of the lung: genuineness and curability. Lung Cancer 39:327–330

    Article  PubMed  Google Scholar 

  • Hof H, Herfarth K, Munter M, Hoess A, Motsch J, Wannenmacher M, Debus J (2003) Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 56:3345–3341

    Article  Google Scholar 

  • Holsti LB, Vuorinen P (1967) Radiation reaction in the lung after continuous and split-course megavoltage radiotherapy of bronchial carcinoma. Br J Radiol 40:280–284

    PubMed  Google Scholar 

  • Ishida T, Yano T, Maeda K (1991) Strategy for lymphadenopathy in lung cancer 3 cm or less in diameter. Ann Thorac Surg 50:708–771

    Google Scholar 

  • Jeremic B, Shibamoto Y, Acimovic LJ, Milisavljevic S (1997) Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 38:521–525

    Article  PubMed  Google Scholar 

  • Jeremic B, Shibamoto Y, Acimovic LJ, Milisavljevic S (1999) Hyperfractionated radiotherapy for clinical stage II nons-mall cell lung cancer. Radiother Oncol 51:141–145

    Article  PubMed  Google Scholar 

  • Jeremic B, Shibamoto Y, Acimovic LJ, Nikolic N, Dagovic A, Aleksandrovic J, Radosavljevic-Asic G (2001) Second cancers occurring in patients with early stage non-small cell lung cancer treated with chest radiation therapy alone. J Clin Oncol 19:1056–1063

    PubMed  Google Scholar 

  • Jeremic B, Classen J, Bamberg M (2002) Radiation therapy alone in technically operable, medically inoperable early stage (I/II) non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 5:119–130

    Article  Google Scholar 

  • Jeremic B, Classen J, Bamberg M (2003a) Re.: Observationonly management of early stage, medically inoperable lung cancer. Do not do that-a loud and a clear radiotherapeutic point of view! Chest 123:313–314

    Article  Google Scholar 

  • Jeremic B, Shibamoto Y, Milicic B, Dagovic A, Nikolic N, Aleksandrovic J, Acimovic L, Milisavljevic S (2003b) Impact of treatment interruptions due to toxicity on outcome of patients with early stage (I/II) non-small-cell lung cancer (NSCLC) treated with hyperfractionated radiation therapy (Hfx RT) alone. Lung Cancer 40:317–323

    PubMed  Google Scholar 

  • Kaskowitz L, Graham MV, Emami B, Halverson KJ, Rush C (1993) Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 27:517–523

    PubMed  Google Scholar 

  • Koike T, Terashima M, Takizawa T, Watanabe T, Kurita Y, Yokoyama A (1998) Clinical analysis of small-sized peripheral lung cancer. J Thorac Cardiovasc Surg 115:1015–1020

    PubMed  Google Scholar 

  • Komaki R, Scott C, Ettinger D, Lee JS, Fossella FV, Curran W, Evans RF, Rubin P, Byhardt RW (1997) Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04. Int J Radiat Oncol Biol Phys 38:149–155

    Article  PubMed  Google Scholar 

  • Kooy HM, Dunbar SF, Tarbell NJ, Mannarino E, Ferarro N, Shusterman S, Bellerive M, Finn L, McDonough CV, Loefflier JS (1994) Adaptation of the relocatable Gill-Thomas-Cosman frame in stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 30: 685–691

    PubMed  Google Scholar 

  • Krol AD, Aussems P, Noordijk EM, Hermans J, Leer JW (1996) Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys 34:297–302

    Article  PubMed  Google Scholar 

  • Kupelian PA, Komaki R, Allen P (1996) Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys 36:607–613

    Article  PubMed  Google Scholar 

  • Kutcher GJ, Burman C (1987) Calculation of probability factors for non-uniform normal tissue irradiation: the effective volume method. Med Phys 14:487

    Google Scholar 

  • Kwa SL, Theuws JC, Wagenaar A, Damen EM, Boersma LJ, Baas P, Muller SH, Lebesque JV (1998) Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. Radiother Oncol 48:61–69

    Article  PubMed  Google Scholar 

  • Lagerwaard FJ, Senan S, van Meerbeeck JP, Graveland WJ (2002) Has 3-D conformal radiotherapy (3D-CRT) improved local tumour control for stage I non-small cell lung cancer? Radiother Oncol 63:151–157

    Article  PubMed  Google Scholar 

  • Langendijk JA, Aaronson NK, ten Velde GPM, de Jong JM, Muller MJ, Wouters EF (2000) Pretreatment quality of life of inoperable non-small cell lung cancer patients referred for primary radiotherapy. Acta Oncol 39:949–958

    Article  PubMed  Google Scholar 

  • Lee JS, Scott C, Komaki R, Fossella FV, Dundas GS, McDonald S, Byhardt RW, Curran WJ Jr (1996) Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: Radiation Therapy Oncology Group protocol 91-06. J Clin Oncol 14:1055–1064

    PubMed  Google Scholar 

  • Lee S, Choi EK, Park HJ, Ahn SD, Kim JH, Kim KJ, Yoon SM, Kim YS, Yi BY (2003) Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer 40:309–315

    PubMed  Google Scholar 

  • Lyman JT, Wolbarst AB (1987) Optimization of radiation therapy III. A method of assessing complication probabilities from dose-volume histograms. Int J Radiat Oncol Biol Phys 13:103–109

    PubMed  Google Scholar 

  • MacManus MP, Hicks RJ, Matthews JP, Hogg A, McKenzie AF, Wirth A, Ware RE, Ball DL (2001) High rate of detection of unsuspected distant metastases by PET in apparent stage III non-small-cell lung cancer: implications for radical therapy. Int J Radiat Oncol Biol Phys 50:287–294

    Article  PubMed  Google Scholar 

  • Maguire PD, Sibley GS, Zhou SM, Jamieson TA, Light KL, Antoine PA, Herndon JE 2nd, Anscher MS, Marks LB (1999) Clinical and dosimetric predictors of radiation-induced esophageal toxicity. Int J Radiat Oncol Biol Phys 45:97–103

    Article  PubMed  Google Scholar 

  • Maguire PD, Marks LB, Sibley GS, Herndon JE 2nd, Clough RW, Light KL, Hernando ML, Antoine PA, Anscher MS (2001) 73.6 Gy and beyond: Hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer. J Clin Oncol 19:705–711

    PubMed  Google Scholar 

  • Mah K, van Dyk J, Keane T, Poon PY (1987) Acute radiation-induced pulmonary damage: a clinical study on the response to fractionated radiation therapy. Int J Radiat Oncol Biol Phys 13:179–188

    PubMed  Google Scholar 

  • Marom EM, McAdams HP, Erasmus JJ, Goodman PC, Culhane DK, Coleman RE, Herndon JE, Patz EF Jr (1999) Staging non-small cell lung cancer with whole-body PET. Radiology 212:803–809

    PubMed  Google Scholar 

  • Martel MK, Ten Haken RK, Hazuka MB, Turrisi AT, Fraass BA, Lichter AS (1994) Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys 28:575–581

    PubMed  Google Scholar 

  • Martel MK, Sahijdak WM, Hayman JA (1999) Incidental dose to clinically negative nodes from conformal treatment fields for nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 45:244 (abstract)

    Article  Google Scholar 

  • Martini N, Beattie E (1977) Results of surgical treatment in stage I lung cancer. J Thorac Cardiovasc Surg 74:499–505

    PubMed  Google Scholar 

  • Maruyama R, Sugio K, Mitsudomi T, Saitoh G, Ishida T, Sugimachi K (1997) Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 114:535–543

    Article  PubMed  Google Scholar 

  • McDonald S, Rubin P, Phillips TL, Marks LB (1995) Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys 31:1187–1203

    Article  PubMed  Google Scholar 

  • McGarry RC, Song G, des Rosiers P, Timmermann R (2002) Observation-only management of early stage, medically inoperable lung cancer. Poor outcome. Chest 121:1155–1158

    Article  PubMed  Google Scholar 

  • Mizushima Y, Noto H, Sugiyama S, Kusajima Y, Yamashita R, Kashii T, Kobayashi M (1997) Survival and prognosis after pneumonectomy for lung cancer in the elderly. Ann Thorac Surg 64:193–198

    Article  PubMed  Google Scholar 

  • Morita K, Fuwa N, Suzuki Y, Nishio M, Sakai K, Tamaki Y, Niibe H, Chujo M, Wada S, Sugawara T, Kita M (1997) Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: retrospective analysis of 149 patients. Radiother Oncol 42:31–36

    Article  PubMed  Google Scholar 

  • Morrison R, Delley TJ, Cleland WP (1963) The treatment of carcinoma of the bronchus. A clinical trial to compare surgery and supervoltage radiotherapy. Lancet 1:683–684

    Article  Google Scholar 

  • Moss WT, Haddy FJ, Sweany SK (1960) Some factors altering the severity of acute radiation pneumonitis: variation with cortisone, heparin, and antibiotica. Radiology 75:50–54

    PubMed  Google Scholar 

  • Mountain CF (1986) A new international staging system for lung cancer. Chest 89:225S–233S

    PubMed  Google Scholar 

  • Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 111:1710–1717

    PubMed  Google Scholar 

  • Movsas B, Scott C, Sause W, Byhardt R, Komaki R, Cox J, Johnson D, Lawton C, Dar AR, Wasserman T, Roach M, Lee JS, Andras JE (1999) The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): A quality-adjusted survival analysis of Radiation Therapy Oncology Group (RTOG) chemoradiation studies. Int J Radiat Oncol Biol Phys 45:1143–1149

    Article  PubMed  Google Scholar 

  • Movsas B, Scott C, Sause W (2000) Age dramatically impacts on the quality-adjusted time without symptoms or toxicity (Q_Twist) in locally advanced non-small cell lung cancer (LA-NSCLC) — a radiation therapy oncology group (RTOG) analysis. Proc 42nd Ann Meet Am Soc Ther Radiol Oncol (abstract 92)

    Google Scholar 

  • Nagata Y, Negoro Y, Aoki T, Mizowaki T, Takayama K, Kokubo M, Araki N, Mitsumori M, Sasai K, Shibamoto Y, Koga S, Yano S, Hiraoka M (2002) Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 52:1041–1046

    Article  PubMed  Google Scholar 

  • Naruke T, Goya T, Tsuchiya R, Suemasu K (1988) Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 96:440–447

    PubMed  Google Scholar 

  • Noordijk EM, von der Poest Clement E, Hermans J, Wever AM, Leer JW (1988) Radiotherapy as an alternative to surgery in elderly patients with respectable lung cancer. Radiother Oncol 13:83–89

    PubMed  Google Scholar 

  • Oetzel D, Schraube P, Hensley F, Sroka-Perez G, Menke M, Flentje M (1995) Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 33:455–460

    Article  PubMed  Google Scholar 

  • Onimaru R, Shirato H, Shimizu S, Kitamura K, Xu B, Fukumoto S, Chang T-C, Fujita K, Oita M, Miyasaka K, Nishimura M, Dosaka-Akita H (2003) Tolerance of organs at riskin small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 56:126–135

    Article  PubMed  Google Scholar 

  • Ono R, Egawa S, Suemasu K, Sakura M, Kitagawa T (1991) Radiotherapy in inoperable stage I lung cancer. Jpn J Clin Oncol 21:125–128

    PubMed  Google Scholar 

  • Passlick B, Izbicki JR, Kubuschok B, Thetter O, Pantel K (1996) Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis. Ann Thorac Surg 61:177–183

    Article  PubMed  Google Scholar 

  • Pastorino U, Andreola S, Tagliabue E, Pezzella F, Incarbone M, Sozzi G, Buyse M, Menard S, Pierotti M, Rilke F (1997) Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J Clin Oncol 15:2858–2865

    PubMed  Google Scholar 

  • Prasad SC (1978) Relation between tolerance dose and treatment field size in radiation therapy. Med Phys 5:430–433

    Article  PubMed  Google Scholar 

  • Robertson JM, Ten Haken RK, Hazuka MB, Turrisi AT, Martel MK, Pu AT, Littles JF, Martinez FJ, Francis IR, Quint LE, Lichter AS (1997) Dose escalation for non-small cell lung cancer using conformal radiation therapy. Int J Radiat Oncol Biol Phys 37:1079–1085

    Article  PubMed  Google Scholar 

  • Rosenthal SA, Curran WJ Jr, Herbert SH, Hughes EN, Sandler HM, Stafford PM, McKenna WG (1992) Clinical stage II non-small cell lung cancer treated with radiation therapy alone. The significance of clinically staged ipsilateral hilar adenopathy (NI disease). Cancer 70:3410–3417

    Google Scholar 

  • Rosenzweig KE, Sim SE, Mychalczak B, Braban LE, Schindelheim R, Leibel SA (2001) Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 50:681–685

    Article  PubMed  Google Scholar 

  • Rubin P, Casarett GW (1968) Clinical radiation pathology. Saunders, Philadelphia, pp 423–470

    Google Scholar 

  • Sandler HM, Curran WJ Jr, Turrisi AT III (1990) The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 19:9–13

    PubMed  Google Scholar 

  • Saunders M, Dische S, Barrett A, Harvey A, Griffiths G, Palmar M (1999) Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. Radiother Oncol 52:137–148

    Article  PubMed  Google Scholar 

  • Saunders CA, Dussek JE, O'Doherty MJ, Maisey MN (1999) Evaluation of Fluorine-18-Fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer. Ann Thorac Surg 76:790–797

    Article  Google Scholar 

  • Sause WT, Scott C, Taylor S, Johnson D, Livingston R, Komaki R, Emami B, Curran WJ, Byhardt RW, Turrisi AT (1995) Radiation Therapy Oncology Group 88-08 and Eastern Cooperative Oncology Group 4588: preliminary results of a phase III trial in regionally advanced, unresectable nons-mall cell lung cancer. J Natl Cancer Inst 87:198–205

    PubMed  Google Scholar 

  • Sawyer TE, Bonner JA, Gould PM, Deschamps C, Lange CM, Li H (1999) Predictors of subclinical nodal involvement in clinical stages I and II non-small cell lung cancer. Implications in the inoperable and three-dimensional dose-escalation settings. Int J Radiat Oncol Biol Phys 43:965–970

    Article  PubMed  Google Scholar 

  • Senan S, Burgers S, Samson MJ, van Klaveren RJ, Oei SS, van Sornsen de Koste J, Voet PW, Lagerwaard FJ, Maarten van Haarst J, Aerts JG, van Meerbeeck JP (2002) Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy. Int J Radiat Oncol Biol Phys 54:999–1006

    Article  PubMed  Google Scholar 

  • Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR (1998) Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: The Duke experience. Int J Radiat Oncol Biol Phys 40:149–154

    Article  PubMed  Google Scholar 

  • Slebos RJ, Kibbelaar RE, Dalesio O, Kooistra A, Stam J, Meijer CJ, Wagenaar SS, Vanderschueren RG, van Zandwijk N, Mooi WJ (1990) K-ras oncogene activation as prognostic marker in adenocarcinoma of lung. N Engl J Med 323:561–566

    PubMed  Google Scholar 

  • Slotman BJ, Karim ABMF (1994) Curative radiotherapy for technically operable stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 29:33–37

    PubMed  Google Scholar 

  • Slotman BJ, Antonisse IE, Njo KH (1996) Limited field irradiation in early stage (T1–2 N0) non-small cell lung cancer. Radiother Oncol 41:41–44

    PubMed  Google Scholar 

  • Smart J (1966) Can lung cancer be cured by irradiation alone? JAMA 195:1034–1035

    Article  PubMed  Google Scholar 

  • Sturm V, Kober H, Hover K-H, Schlegel W, Boesecke R, Pastyr O, Hartmann GH, Schabbert S, zum Winkel K, Kunze S (1987) Stereotactic percutaneous single dose irradiation of brain metastasis with a linear accelerator. Int J Radiat Oncol Biol Phys 13:279–282

    PubMed  Google Scholar 

  • Suzuki K, Nagai K, Yoshida J, Nishimura M, Takahashi K, Nishiwaki Y (1999) Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. J Thorac Cardiovasc Surg 117:593–598

    PubMed  Google Scholar 

  • Suzuki K, Nagai K, Yoshida J, Nishimura M, Nishiwaki Y (2001) Predictors of lymph node and intrapulmonary metastasis in clinical stage IA non-small cell lung carcinoma. Ann Thorac Surg 72:352–356

    Article  PubMed  Google Scholar 

  • Takizawa T, Terashima M, Koike T, Watanabe T, Kurita Y, Yokoyama A, Honma K (1998) Lymph node metastasis in small peripheral adenocarcinoma of the lung. J Thorac Cardiovasc Surg 116:276–280

    PubMed  Google Scholar 

  • Talton BM, Constable WC, Kersh CR (1990) Curative radiotherapy for technically operable Stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 19:15–21

    PubMed  Google Scholar 

  • Tateishi M, Ishida T, Mitsudomi, Kaneko S, Sugimachi K (1991) Prognostic value of c-erB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. Eur J Cancer 27:1372–1375

    PubMed  Google Scholar 

  • Timmerman R, Papiez L, McGarry R, Likes L, DesRosiers C, Frost S, Williams M (2003) Extracranial stereotactic radioablation. Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 123:1946–1955

    Article  Google Scholar 

  • Uematsu M, Shioda A, Tahara K, Fukui T, Yamamoto F, Tsumatori G, Ozeki Y, Aoki T, Watanabe M, Kusano S (1998) Focal, high-dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients. A preliminary experience. Cancer 82:1062–1070

    Article  PubMed  Google Scholar 

  • Uematsu M, Shioda A, Suda A, Fukui T, Ozeki Y, Hama Y, Wong JR, Kusano S (2001) Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small-cell lung cancer: a year experience. Int J Radiat Oncol Biol Phys 51:666–670

    Article  PubMed  Google Scholar 

  • Varlotto JM, Shieeve DC, Alexander E III, Kooy HM, Black PM, Loeffler JS (1996) Fractionated stereotactic radiotherapy for the treatment of acoustic neuromas: preliminary results. Int J Radiat Oncol Biol Phys 36:141–145

    Article  PubMed  Google Scholar 

  • Whittle J, Steinberg EP, Anderson G, Herbert R (1991) Use of Medicare claims data to evaluate outcomes in elderly patients undergoing lung resection for lung cancer. Chest 100:729–734

    PubMed  Google Scholar 

  • Whyte RI, Crownover R, Murphy MJ, Martin DP, Rice TW, DeCamp M Jr, Rodebaugh R, Weinhous MS, Le Q-T (2003) Stereotactic radiosurgery for lung tumors: preliminary results of a phase I trial. Ann Thorac Surg 75:1097–1101

    Article  PubMed  Google Scholar 

  • Williams TE, Thomas CR Jr, Turrisi AT III (2000) Better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation. Semin Rad Oncol 10:315–323

    Google Scholar 

  • Wu J, Ohta Y, Minato H, Tsunezuka Y, Oda M, Watanabe Y, Watanabe G (2001) Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less I ndiameter. Ann Thorac Surg 71:1772–1777

    Article  PubMed  Google Scholar 

  • Zhang HX, Yin WB, Zhang LJ, Yang ZY, Zhang ZX, Wang M, Chen DF, Gu XZ (1989) Curative radiotherapy of early operable non-small cell lung cancer. Radiother Oncol 14:89–94

    Article  PubMed  Google Scholar 

  • Zierhut D, Bettscheider C, Schubert K, van Kampen M, Wannenmacher M (2001) Radiation therapy of stage I and II non-small cell lung cancer (NSCLC). Lung Cancer 34[Suppl 3]:S39–43

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Jeremić, B. (2005). Radiotherapy in Early Stage Non-Small Cell Lung Cancer. In: Jeremić, B. (eds) Advances in Radiation Oncology in Lung Cancer. Medical Radiology Radiation Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26632-1_13

Download citation

  • DOI: https://doi.org/10.1007/3-540-26632-1_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-00522-3

  • Online ISBN: 978-3-540-26632-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics